Differential Diagnoses for Productive Cough
Acute Productive Cough (< 3 weeks)
Acute viral upper respiratory infection is by far the most common cause of productive cough lasting less than 3 weeks. 1, 2
- Viral bronchitis accounts for >90% of acute productive cough cases, typically presenting with rhinitis, pharyngitis, mild fever, and malaise. 3, 2
- Community-acquired pneumonia must be ruled out when fever >38°C, tachycardia >100 bpm, tachypnea >24 breaths/min, or abnormal chest exam findings (rales, egophony, tactile fremitus) are present. 3, 2
- Pertussis (whooping cough) should be considered when cough ≥2 weeks is accompanied by paroxysmal episodes, post-tussive vomiting, or inspiratory "whoop," especially with documented community transmission. 1, 2
Critical pitfall: Purulent or discolored sputum does NOT indicate bacterial infection—it reflects inflammatory cells and sloughed epithelium, not pathogenic bacteria. 3
Chronic Productive Cough (> 8 weeks)
The four most common causes—upper airway cough syndrome (UACS), asthma, gastroesophageal reflux disease (GERD), and non-asthmatic eosinophilic bronchitis (NAEB)—account for 92-100% of chronic productive cough cases in nonsmokers not taking ACE inhibitors. 4, 1
Primary Etiologies (in order of frequency):
1. Upper Airway Cough Syndrome (UACS) – 33-48% of cases 1
- Formerly called post-nasal drip syndrome; may present as "silent PNDS" where cough is the only symptom despite underlying rhinosinus disease. 1
- Diagnosis is clinical; trial a topical nasal corticosteroid for 1 month or first-generation antihistamine/decongestant combination. 1
2. Asthma – 16-25% of cases 1
- "Cough-variant asthma" can occur without wheeze or dyspnea. 1
- Confirm with bronchial hyperresponsiveness testing (methacholine challenge) when spirometry is normal. 1
- A 2-week oral corticosteroid trial determines responsiveness; positive response warrants inhaled corticosteroids. 1
3. Gastroesophageal Reflux Disease (GERD) – Third most common 1
- Often manifests as "silent GERD" without heartburn or regurgitation. 1
- Requires intensive acid suppression with proton-pump inhibitor for at least 2 months; shorter courses are ineffective. 1
4. Non-Asthmatic Eosinophilic Bronchitis (NAEB) – 5-33% of cases 1
- Characterized by eosinophilic airway inflammation, normal spirometry, and absence of bronchial hyperresponsiveness. 4, 1
- Diagnosed via induced sputum eosinophil analysis; responds predictably to inhaled or oral corticosteroids. 4, 1
- Should be considered early because it is relatively easy to diagnose and treat. 4
Critical insight: Multiple etiologies frequently coexist—up to 92-100% of patients have one or more of these four conditions either alone or in combination. 1
Secondary Causes of Chronic Productive Cough
Bronchiectasis 5
- Consider when productive cough is associated with recurrent infections, copious purulent sputum, or history of childhood respiratory illness. 5
- Requires high-resolution CT chest for diagnosis. 5
Chronic bronchitis/COPD 1
- Accounts for 4-12% of chronic cough cases, predominantly in current or former smokers. 1
Immunodeficiency 5
- Suspect in patients with recurrent sinopulmonary infections and productive cough. 5
Protracted bacterial bronchitis (PBB) 5
- An emerging adult diagnosis for idiopathic chronic productive cough that responds to low-dose macrolide therapy. 5
Rare but Important Causes
ACE inhibitor-induced cough 1
- Occurs in a notable subset; cessation leads to resolution within 1-4 weeks. 1
- Always review and discontinue ACE inhibitors or sitagliptin during initial evaluation. 1
Post-infectious cough (3-8 weeks duration) 4, 2
- Many experts believe most cases represent persistent UACS, transient bronchial hyperresponsiveness, or prolonged airway inflammation rather than a distinct entity. 4
- Treat with inhaled ipratropium bromide first-line; add inhaled corticosteroids only if quality of life is impaired and ipratropium fails. 2
Bordetella pertussis 4
- May be etiologic in localized epidemics or perpetuate chronic cough by provoking GERD. 4
Rare structural/neoplastic causes 4
- Endobronchial tumors, tuberculosis, sarcoidosis, retained foreign body, mediastinal mass, or tracheobronchopathia osteochondroplastica. 4, 6
Red-Flag Symptoms Requiring Immediate Evaluation
Any of the following mandate urgent investigation: 1
- Hemoptysis 1
- New or changed cough in smokers >45 years or adults 55-80 years with ≥30 pack-year history 1
- Prominent dyspnea at rest or nocturnal dyspnea 1
- Hoarseness 1
- Fever, unintended weight loss, or peripheral edema 1
- Dysphagia or recurrent pneumonia 1
Diagnostic Algorithm
Step 1: Obtain chest radiograph and spirometry with bronchodilator reversibility as mandatory baseline investigations. 1
Step 2: Review medications—discontinue ACE inhibitors or sitagliptin. 1
Step 3: Screen for environmental/occupational exposures (tobacco, workplace irritants, indoor allergens). 1
Step 4: Systematically evaluate for UACS, asthma, GERD, and NAEB—alone or in combination—as these account for the overwhelming majority of cases. 4, 1
Step 5: If initial evaluation is unrevealing, assess for eosinophilic airway inflammation (sputum eosinophils or exhaled nitric oxide) to identify NAEB. 1
Step 6: Consider bronchial hyperresponsiveness testing (methacholine challenge) when asthma is suspected but spirometry is normal. 1
Critical pitfall: The character, timing, or productivity of cough does NOT provide diagnostic discrimination and should not be used to rule in or out specific etiologies. 4, 1
Management Principles
Treat empirically for the most common causes (UACS, asthma, GERD) even when "silent" (no other symptoms). 4, 1
Quantify cough severity with a validated tool (e.g., Leicester Cough Questionnaire) before and after treatment to objectively assess response. 1
Schedule follow-up 4-6 weeks after initial evaluation; if cough persists, proceed to the next sequential therapeutic trial. 1
Refer to a specialized cough clinic if cough remains refractory after completing guideline-based trials. 1